ad

Caplin Point Laboratories Q2 Results FY27: Revenue Climbs 17.94% to Rs 629.84 Cr, PAT Rs 182.35 Cr

12 Nov 2026 • 1:26 pm

Caplin Point Laboratories Q2 Results FY27: Revenue Climbs 17.94% to Rs 629.84 Cr, PAT Rs 182.35 Cr

Quick Answer

Caplin Point Laboratories Q2 Results FY27 were declared on 12 November 2026 on a consolidated basis. The quarterly results show revenue of Rs 629.84 Cr, up 17.94% from Rs 534.04 Cr a year earlier. Net profit stood at Rs 182.35 Cr against Rs 160.23 Cr, a YoY rise of 13.81%, while Operating Profit rose 18.00% to Rs 223.22 Cr.

Caplin Point Laboratories Ltd (CAPLIPOINT) Q2 Results FY27 announced on 12 November 2026, covering the company's financial performance for the July to September quarter. The results date brought Consolidated revenue of Rs 629.84 Cr and PAT of Rs 182.35 Cr. Caplin Point Laboratories Q2 Results FY27 therefore show revenue and net profit both moving up year on year, and these consolidated results are unpacked below.

This results analysis covers the financial highlights, business drivers, outlook and risks behind Caplin Point Laboratories Q2 Results. Univest tracks these figures so readers can compare them quickly, and the table that follows sets out each metric against the same quarter last year.

Click Here – Get Free Investment Predictions

Caplin Point Laboratories Q2 Results FY27: Financial Highlights

Metric Q2 FY27 (Sep 26) Q2 FY26 (Sep 25) YoY Change
Revenue Rs 629.84 Cr Rs 534.04 Cr +17.94% YoY
Operating Profit Rs 223.22 Cr Rs 189.17 Cr +18% YoY
Net Profit (PAT) Rs 182.35 Cr Rs 160.23 Cr +13.81% YoY

Source: company filing for Caplin Point Laboratories Q2 Results FY27, 12 November 2026. Figures in Rs Crore, Consolidated basis.

Key Takeaways from Caplin Point Laboratories Q2 Results: What Stands Out

  • Revenue Rs 629.84 Cr: sales climbed 17.94% from Rs 534.04 Cr in the same quarter last year, a sharp YoY growth figure for the business.
  • Net profit Rs 182.35 Cr: profit after tax rose 13.81% from Rs 160.23 Cr, so net profit grew alongside revenue.
  • Operating Profit Rs 223.22 Cr: this line grew 18.00% from Rs 189.17 Cr, a similar pace to the 17.94% rise in revenue.
  • Net profit margin 29.0%: the margin narrowed from 30.0% in the comparison quarter, measured on the same consolidated basis.
  • Return on equity: Caplin Point Laboratories Q2 Results FY27 sit alongside a return on equity of 20.79% in FY26.
  • Risk headline: the net profit margin narrowed to 29.0% from 30.0%, which leads into the detailed performance analysis that follows.

Caplin Point Laboratories Q2 Results FY27: Performance Analysis

The numbers show revenue of Rs 629.84 Cr, net profit of Rs 182.35 Cr and Operating Profit of Rs 223.22 Cr. Caplin Point Laboratories Q2 Results FY27 therefore record YoY growth of 17.94% in revenue and 18.00% in Operating Profit, alongside a YoY rise of 13.81% in net profit, on a consolidated basis.

Revenue rose from Rs 534.04 Cr to Rs 629.84 Cr and Operating Profit from Rs 189.17 Cr to Rs 223.22 Cr, while net profit moved from Rs 160.23 Cr to Rs 182.35 Cr. In this results analysis, net profit grew more slowly than revenue, which is why the net profit margin sits at 29.0% against 30.0%. These are the quarterly results that investors will weigh first.

Readers following Caplin Point Laboratories Q2 Results can use the Univest Screener to place this quarter beside earlier periods. The figures confirm what changed but do not establish the specific cause, so the next step is the disclosed drivers, and those business factors come next.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Revenue Growth – The business factors start with sales, as revenue grew 17.9% year on year to Rs 629.84 Cr in the latest quarter. This is the largest single move in the disclosed set and anchors the rest of the quarter.

Net Profit Growth – Net profit rose 13.8% year on year to Rs 182.35 Cr, and Caplin Point Laboratories Q2 Results FY27 show this gain beside the revenue increase, as the Financial Highlights table shows.

Consistent Revenue and Returns – Revenue has risen in each of the last 4 quarters, and return on equity was 20.79% in FY26, which are the remaining disclosed factors behind the latest quarter.

FY27 Outlook After Caplin Point Laboratories Q2 Results

FY27 full-year results will depend on subsequent quarters and on disclosed sector conditions. Caplin Point Laboratories Q2 Results FY27 give a reference point of Rs 629.84 Cr in revenue and Rs 182.35 Cr in net profit, and each new filing will show how that base develops.

This results analysis suggests investors will track whether net profit holds near its latest level and whether the 29.0% net profit margin changes in later filings. Updates can be followed in the Univest app, and that watch list leads naturally to the risks that deserve equal attention.

Key Risks to Watch After Caplin Point Laboratories Q2 Results FY27

Narrower Net Profit Margin

Net profit margin narrowed to 29.0% from 30.0% in the comparison quarter, so each rupee of revenue converted to slightly less net profit than a year earlier, a point investors can compare across later filings.

Lower Return on Equity

Return on equity declined to 20.79% in FY26 from 21.72% in FY25, so the latest consolidated quarter can be weighed against this annual return figure in later filings.

Lower Return on Capital Employed

Return on capital employed declined to 24.97% in FY26 from 26.22% in FY25, which is a second annual return measure that investors can track alongside quarterly results.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

Caplin Point Laboratories Q2 Results FY27 show revenue of Rs 629.84 Cr and net profit of Rs 182.35 Cr, with revenue and net profit both higher than a year ago. These consolidated results and quarterly results also carry a narrower margin, so later filings matter. Readers tracking Caplin Point Laboratories Q2 Results should consult a SEBI-registered advisor before acting.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.

Frequently Asked Questions on Caplin Point Laboratories Q2 Results FY27

What are Caplin Point Laboratories Q2 Results FY27?

Ans. Caplin Point Laboratories Q2 Results FY27 cover the July to September 2026 quarter, with revenue of Rs 629.84 Cr. Alongside this, net profit came in at Rs 182.35 Cr, as the opening Quick Answer summarises.

What is the results date for Caplin Point Laboratories Q2 Results FY27?

Ans. Caplin Point Laboratories Q2 Results FY27 were declared on 12 November 2026, which is the results date. This date is stated in the introduction, so readers can match it with the exchange filing.

What revenue was reported in Caplin Point Laboratories Q2 Results FY27?

Ans. Caplin Point Laboratories reported consolidated revenue of Rs 629.84 Cr in Q2 FY27, compared with Rs 534.04 Cr a year earlier. This comparison appears in the Financial Highlights table and in the performance analysis.

What net profit was reported in Caplin Point Laboratories Q2 Results FY27?

Ans. Caplin Point Laboratories reported net profit of Rs 182.35 Cr in the quarter, against Rs 160.23 Cr a year earlier. This net profit figure is covered in the Key Takeaways section.

How much YoY growth did revenue show in Caplin Point Laboratories Q2 Results FY27?

Ans. Revenue showed YoY growth of 17.94% in the quarter, moving from Rs 534.04 Cr to Rs 629.84 Cr. Alongside this, net profit rose 13.81%, as the performance analysis explains.

Did net profit rise or fall in Caplin Point Laboratories Q2 Results?

Ans. In Caplin Point Laboratories Q2 Results, net profit rose to Rs 182.35 Cr from Rs 160.23 Cr, a rise of 13.81% YoY. This means profit grew a little slower than revenue, as the performance analysis shows.

What was the Operating Profit in Caplin Point Laboratories Q2 Results FY27?

Ans. Operating Profit for Caplin Point Laboratories was Rs 223.22 Cr, up 18.00% from Rs 189.17 Cr a year earlier. This line is also listed among the Key Takeaways from the results.

Are Caplin Point Laboratories Q2 Results consolidated results or standalone results?

Ans. Caplin Point Laboratories Q2 Results are consolidated results, covering the company on a consolidated basis. This basis is stated in the Quick Answer and applies to every figure in the Financial Highlights table.

What business factors shaped Caplin Point Laboratories Q2 Results FY27?

Ans. Caplin Point Laboratories disclosed revenue growth of 17.9% year on year, net profit up 13.8% year on year and revenue higher in each of the last 4 quarters. These drivers are detailed in the Key Business Factors section.

What are the key risks after Caplin Point Laboratories Q2 Results FY27?

Ans. The net profit margin narrowed to 29.0% from 30.0%, and return on equity declined to 20.79% in FY26. These risks are set out in the Key Risks to Watch section.

What is the outlook after Caplin Point Laboratories Q2 Results?

Ans. FY27 full-year results will depend on subsequent quarters and on disclosed sector conditions. This outlook section notes that each new filing will show how the latest base develops.

Where can I find the complete Caplin Point Laboratories Q2 Results FY27 data?

Ans. The complete figures sit in the Financial Highlights table above, which compares each metric with the same quarter last year. Readers can also use the Univest Screener for further quarterly results.


Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down